Table 2

Healthcare utilization, HNR study, Germany*

Full sampleNormal fasting glycemiaImpaired fasting glycemiaPreviously undetected diabetesPreviously diagnosed diabetes
(N=1709)(N=951)(N=403)(N=105)(N=250)
Inpatient care per person and year (mean, 95% CI)
Mean number of hospitalizations0.32 (0.29 to 0.37)0.29 (0.25 to 0.34)0.30 (0.24 to 0.38)0.51 (0.24 to 1.33)0.42 (0.33 to 0.55)
Mean duration per hospitalization2.41 (2.09 to 2.81)2.12 (1.74 to 2.64)2.20 (1.65 to 3.00)2.62 (1.38 to 5.65)3.94 (2.86 to 5.54)
Outpatient care per person and year
Number of quarters with at least one outpatient utilization %† (95% CI‡)
 08.9 (7.6 to 10.4)9.8 (7.8 to 12.0)8.6 (6.1 to 11.9)9.5 (4.7 to 16.4)7.8 (4.9 to 12.2)
 14.3 (3.4 to 5.5)4.9 (3.6 to 6.5)4.0 (2.3 to 6.5)6.0 (2.3 to 12.5)1.6 (0.4 to 4.8)
 27.5 (6.3 to 8.9)8.0 (6.3 to 10.0)9.8 (7.2 to 13.3)5.7 (2.4 to 10.9)2.7 (1.0 to 5.8)
 313.3 (11.8 to 15.0)14.7 (12.6 to 17.3)14.9 (11.5 to 18.8)14.8 (8.5 to 22.7)3.2 (1.3 to 6.7)
 466.0 (63.7 to 68.2)62.6 (59.5 to 65.7)62.7 (57.8 to 67.4)64.1 (54.6 to 73.1)84.8 (79.2 to 89.3)
Mean number of outpatient contacts (multiple answers possible)† (95% CI‡)9.29 (8.99 to 9.60)8.99 (8.61 to 9.37)9.08 (8.49 to 9.77)8.40 (7.17 to 10.38)10.89 (9.97 to 11.86)
 Outpatient contacts with EBM reimbursement (German compensation scheme)9.27 (8.97 to 9.57)8.97 (8.59 to 9.35)9.08 (8.48 to 9.77)8.38 (7.16 to 10.36)10.85 (9.93 to 11.81)
 Outpatient contacts associated with costs for dialysis equipment0.008 (0.002 to 0.024)0.005 (0.000 to 0.026)0.026 (0.000 to 0.095)0.00.0
 Outpatient contacts with extrabudgetary services0.79 (0.72 to 0.87)0.76 (0.68 to 0.87)0.72 (0.58 to 0.88)0.62 (0.38 to 0.96)1.05 (0.81 to 1.36)
 Other outpatient services4.42 (4.21 to 4.62)4.05 (3.81 to 4.31)4.26 (3.86 to 4.72)3.71 (2.92 to 5.19)6.10 (5.44 to 6.83)
Medication per person and year (mean, 95% CI)
Mean number of total drugs11.59 (11.02 to 12.20)9.83 (9.18 to 10.55)10.45 (9.53 to 11.56)12.01 (9.42 to 16.96)19.82 (17.90 to 22.11)
 Mean number of cardiovascular drugs4.06 (3.80 to 4.34)3.22 (2.90 to 3.60)3.97 (3.49 to 4.53)4.83 (3.81 to 5.98)7.25 (6.38 to 8.31)
 Mean number of total drugs without antihyperglycemic drugs (ATC A10)10.96 (10.41 to 11.52)9.83 (9.18 to 10.55)10.45 (9.53 to 11.56)12.01 (9.42 to 16.96)15.51 (13.89 to 17.50)
  • *Study period: four complete quarters before the follow-up examination (ie, 1 year).

  • †Age-standardized and sex-standardized; standard: German population 31 December 2006 (http://www.destatis.de).

  • ‡BCA-method using bootstrap procedure.

  • ATC, anatomical therapeutic chemical; EBM, einheitlicher bewertungsmaßstab; HNR, Heinz Nixdorf Recall study.